Please login to the form below
Middle East
This page shows the latest Middle East news and features for those working in and with pharma, biotech and healthcare.
GCI Health announces expansion into the Middle East
GCI Health Middle East will be led by Kath Kerry, president – Europe &Middle East. ... Healthcare agency GCI Health has announced its expansion into the Middle East, with the new division set to be led by Kath Kerry (pictured above), president –
Latest news
-
Avenir Global moves four UK agencies into new office space in London
It has over 1, 000 staff and offices in 23 locations across Canada, the US, Europe and the Middle East, ranking among the top 15 largest communications firms globally.
-
J&J’s multiple sclerosis therapy Ponvory moves closer to EU approval
Relapsing forms of multiple sclerosis have varied and often unpredictable symptoms, posing a unique human, societal and economic burden,” said Catherine Taylor, vice president, medical affairs therapeutic area strategy, Europe, Middle ... East and
-
bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
Although there are many cases of thalassaemia among people of Mediterranean, Middle Eastern, South and East Asian and African descent, global population movements mean that the disease now occurs across the
-
Janssen’s Erleada improves survival in certain advanced prostate cancer patients
cancer,” said Catherine Taylor, vice-president, medical affairs therapeutic area strategy for Europe, Middle East and Africa, Johnson &Johnson Middle East.
-
Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer
for Europe, Middle East and Africa at Janssen.
Avenir Global moves four UK agencies into new office space in London
J&J’s multiple sclerosis therapy Ponvory moves closer to EU approval
bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
Janssen’s Erleada improves survival in certain advanced prostate cancer patients
More from news
Approximately 1 fully matching, plus 137 partially matching documents found.
Latest Intelligence
-
Unlocking the potential of precision medicine in oncology
More specifically, through our ORACULUM studies, we are using AI to analyse patient-level data that is collected through electronic health records across numerous countries in Europe, the Middle East and
-
As COVID-19 takes over the world, biopharma fights back
respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
-
Keeping up the fight against HIV and using the lessons to tackle other threats
their big budget spreadsheets,” said Mike Elliott (pictured above), Vice President of Medical Affairs for Europe, Middle East &Australasia for Gilead Sciences.
-
Leading AstraZeneca’s return to growth in Europe
Care in Central and Eastern Europe, Middle East and Africa before landing the general manager role in Russia in 2014.
-
Bluebird: on a mission to ‘recode’ the DNA of healthcare
Obenshain insisted, however, that Bluebird is investing for a long-term independent future, with its sights also set on taking Zynteglo into the Middle East and Asia, where beta thalassemia patients
Unlocking the potential of precision medicine in oncology
As COVID-19 takes over the world, biopharma fights back
Keeping up the fight against HIV and using the lessons to tackle other threats
Leading AstraZeneca’s return to growth in Europe
Bluebird: on a mission to ‘recode’ the DNA of healthcare
More from intelligence
Approximately 0 fully matching, plus 31 partially matching documents found.
Latest appointments
-
GCI Health’s UK team announces three senior promotions
Walker, Morris and Yianni will report to Kath Kerry, who was recently named as GCI Health's president of Europe &Middle East.
-
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
Umberto La Magna has decided to join Sinclair Pharma, taking up the role of head of Central and Eastern Europe and Middle East and Africa regions. ... Most recently, La Magna held the role of head of central south-east Europe for Baxter International,
-
Pharnext appoints COO
Before joining Pharnext, Kohli was general manager of clinical diagnostics at Eurofins based in Brussels, where he led business expansion across Europe and the Middle East.
-
Anish Mehta appointed CEO of new women's health business
Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.
-
Bayer UK and Ireland appoints new CEO
Prior to that Bruening held senior commercial roles in Europe, the Middle East and Asia, bringing knowledge in the pharmaceutical sector, international healthcare landscape and global commercial markets to the group.
GCI Health’s UK team announces three senior promotions
New hires at Mundipharma, Sinclair Pharma and Relay Therapeutics
Pharnext appoints COO
Anish Mehta appointed CEO of new women's health business
Bayer UK and Ireland appoints new CEO
More from appointments
Approximately 0 fully matching, plus 34 partially matching documents found.
Latest from PMHub
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
9. The team at Oxford were using the viral vector approach, which they had previously used to make candidate vaccines in outbreaks of flu, Zika and Middle East Respiratory Syndrome (MERS).
-
Deep 6 AI: the smart software breathing new life into clinical trials
This mission saw him become a diplomat in the Middle East, a McKinsey consultant in Asia, and take on roles in international intelligence before realizing he could use his knowledge and
-
Dovetail partners with Tillotts AG to map management of C. difficile infection in Europe
Tillotts Pharma AG recently acquired the rights to DIFICLIR from Astellas Pharma Europe Ltd for Europe, Middle East, Africa and selected CIS.
-
Lucid Group Evolve and Simplify its Brand Architecture
Seven months later, in September 2019, Lucid Group acquired HealthCare21 – increasing its footprint in the UK, Asia Pacific and Middle East along with specific expertise in digital strategy, medical writing, editing
-
GLOBALHealthPR® Welcomes Exclusive France Partner Agency
GLOBALHealthPR's presence spans more than 60 countries, covering Europe, North America, Latin America, the Middle East, Africa and Asia-Pacific.
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
More from PMHub
Approximately 1 fully matching, plus 27 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- US demand for COVID-19 antibody treatments rising fast
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- COVID-19 Pfizer/BioNTech booster approved by FDA and CDC
- AstraZeneca invests in RNA tech platform
- Market shaping demands behaviour change
- Healthcare Access and Payment Reform in the US
- Advancing Drug Discovery with Structured and Intelligent Data
- Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
- David Hunt launches independent agency The Considered
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Oxford PharmaGenesis wins Communiqué Medical Affairs Agency of the Year award at Communiqué 2021
- FDA’s director and deputy director of its Office of Vaccines Research & Review resign
- $47.5m research centre to seek genetic insights into disease
- New data from Moderna supports COVID boosters
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
